Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine

Radiology

Volumn 202, Issue 1, 1997, Pages 177-182

  Rofsky, Neil M ^a   Purdy, David E ^b   Johnson, Glyn ^a   DeCorato, Douglas R ^a   Earls, James P ^a   Krinsky, Glenn ^a   Weinreb, Jeffrey C ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

Angiography, comparative studies; Arteries, extremities; Arteries, peripheral; Magnetic resonance (MR), comparative studies; Magnetic resonance (MR), contrast enhancement; Magnetic resonance (MR), time of flight; Magnetic resonance (MR), vascular studies

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

EID: 0031030148     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.202.1.8988209     Document Type: Article

References (13)

1. Felmlee J, Ehman R. Spatial presaturation: a method for suppressing flow artifacts and improving depiction of vascular anatomy. Radiology 1987; 164:559-564.
2. Selby K, Saloner D, Anderson C, et al. MR angiography with a cardiac-phase-specific acquisition window. JMRI 1992; 2:637-643.
3. Yucel EK, Silver MS, Carter AP. Comparison of signal intensity and contrast-to-noise ratio for three different inflow techniques. AJR 1994; 163:197-201.
4. Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. JAMA 1995; 274:875-880.
5. Owen RS, Baum RA, Carpenter JP, Holland GA, Cope C. Symptomatic peripheral vascular disease: selection of imaging parameters and clinical evaluation with MR angiography. Radiology 1993; 187:627-635.
6. Snidow JJ, Harris VJ, Johnson MS, et al. Iliac artery evaluation with two-dimensional time-of-flight MR angiography: update. JVIR 1996; 7:213-220.
7. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994; 191:155-164.
8. Adamis MK, Li W, Wielopolski PA, et al. Dynamic contrast-enhanced subtraction MR angiography of the lower extremities: initial evaluation with a multisection two-dimensional time-of-flight sequence. Radiology 1995; 196:689-695.
9. Snidow JJ, Aisen AM, Harris VJ, et al. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology 1995; 196:371-378.
10. Douek PC, Revel D, Chazel S, Falise B, Villard J, Amiel M. Fast MR angiography of the aortoiliac arteries and arteries of the lower extremity: value of bolus-enhanced, whole-volume subtraction technique. AJR 1995; 165:431-437.
11. Marchai G, Bosmans H, McLachlan SJ. Magnetopharmaceuticals as contrast agents. In: Potchen EJ, Haacke EM, Siebert JE, Gottschalk A, eds. Magnetic resonance angiography concepts and applications. St Louis, Mo: Mosby-Year Book, 1993; 305-322.
12. Purdy DE, Simonetti O, Finn JP. Overlapping travelling saturation bands for background suppression in 2-D time-of-flight angiography (abstr). In: Proceedings of the Society of Magnetic Resonance 1994. Berkeley, Calif: Society of Magnetic Resonance, 1994; 954.
13. Tweedle MF. Physiochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest Radiol 1992; 27(suppl):2-6.